Stay updated on Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial

Sign up to get notified when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a PubMed auto-fill notice for publications and updated the page revision to v3.3.2; removed the older PubMed note and the v3.2.0 revision label.
    Difference
    0.1%
    Check dated 2025-11-24T17:02:34.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the Study Details page for NCT02720094; the notice informed users that information may not be up to date due to funding lapses and directed readers to cc.nih.gov and opm.gov.
    Difference
    0.2%
    Check dated 2025-11-17T15:04:03.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The new screenshot shows cosmetic formatting changes to the Study Details page, with no changes to the study design, eligibility criteria, primary outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:32:31.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    No substantive changes detected in core content, pricing, stock, or time slot availability. The addition and deletion simply swap the label from “Last Update Posted” to “Last Update Posted (Estimated),” which does not alter meaning or important information.
    Difference
    0.0%
    Check dated 2025-10-19T16:56:03.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The additions introduce new content describing how diastolic and systolic blood pressure changes from baseline are calculated, table descriptions, and new date entries (including 2025-03-31 and 2025-09-23), while deletions remove an active recruitment status and earlier date markers (e.g., 2024-11 and 2016-12). Overall, the page gains the explicit definitions and timing for BP change reporting, with some removal of recruitment-status and older date references.
    Difference
    2%
    Check dated 2025-10-12T15:45:17.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added site operating-status notice and a new study citation; updated revision tag from v3.1.0 to v3.2.0. The core content and references are updated, while the revision label itself is a metadata change.
    Difference
    3%
    Check dated 2025-10-05T11:56:27.000Z thumbnail image

Stay in the know with updates to Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.